Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5029)
All Articles published online
|
Dec 28, 2011 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qiu Y, Xu MB, Yun MM, Wang YZ, Zhang RM, Meng XK, Ou-Yang XH, Yun S. Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells. World J Gastroenterol 2011; 17(48): 5260-5266 [PMID: 22219594 DOI: 10.3748/wjg.v17.i48.5260] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i48/5260.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Ying Qiu, Mark M. Yun, Xuebin Dong, Mingbao Xu, Ruidong Zhao, Xia Han, Erxia Zhou, Feiyu Yun, Wuyun Su, Caixia Liu, Haiyan Zhao, Xin Tong, Jin Gao, Xiaohui Ouyang, Sheng Yun. Combination of cytokine-induced killer and dendritic cells pulsed with antigenic α-1,3-galactosyl epitope–enhanced lymphoma cell membrane for effective B-cell lymphoma immunotherapy. Cytotherapy 2016; 18(1): 91 doi: 10.1016/j.jcyt.2015.09.012
|
| 3 |
Uri Galili. Self-Tumor Antigens in Solid Tumors Turned into Vaccines by α-gal Micelle Immunotherapy. Pharmaceutics 2024; 16(10): 1263 doi: 10.3390/pharmaceutics16101263
|
| 4 |
Eishiro Mizukoshi, Shuichi Kaneko. Inflammation and Immunity in Cancer. 2015; : 123 doi: 10.1007/978-4-431-55327-4_10
|
| 5 |
Yaojie Fu, Shanshan Liu, Shan Zeng, Hong Shen. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1396-4
|
| 6 |
Fengzhen Mo, Dabing Xue, Siliang Duan, Aiqun Liu, Xiaomei Yang, Xiaoqiong Hou, Xiaoling Lu. Novel fusion cells derived from tumor cells expressing the heterologous α-galactose epitope and dendritic cells effectively target cancer. Vaccine 2019; 37(7): 926 doi: 10.1016/j.vaccine.2019.01.004
|
| 7 |
Nicolò Brandi, Matteo Renzulli. The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(10): 8598 doi: 10.3390/ijms24108598
|
| 8 |
Shasha Song, Pingfan Yuan, Peipei Li, Huaxun Wu, Jingtao Lu, Wei Wei. Dynamic analysis of tumor-associated immune cells in DEN-induced rat hepatocellular carcinoma. International Immunopharmacology 2014; 22(2): 392 doi: 10.1016/j.intimp.2014.07.007
|
| 9 |
Ying Zhang, Ingo G. H. Schmidt‐Wolf. Ten‐year update of the international registry on cytokine‐induced killer cells in cancer immunotherapy. Journal of Cellular Physiology 2020; 235(12): 9291 doi: 10.1002/jcp.29827
|
| 10 |
Clara E Jäkel, Ingo GH Schmidt-Wolf. An update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cells. Expert Opinion on Biological Therapy 2014; 14(7): 905 doi: 10.1517/14712598.2014.900537
|
| 11 |
Nobuhiro Tsuchiya, Yu Sawada, Itaru Endo, Yasushi Uemura, Tetsuya Nakatsura. Potentiality of immunotherapy against hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(36): 10314-10326 doi: 10.3748/wjg.v21.i36.10314
|
| 12 |
Jesús Prieto, Ignacio Melero, Bruno Sangro. Immunological landscape and immunotherapy of hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 2015; 12(12): 681 doi: 10.1038/nrgastro.2015.173
|
| 13 |
Jimmy Charneau, Toshihiro Suzuki, Manami Shimomura, Norihiro Fujinami, Tetsuya Nakatsura. Peptide-Based Vaccines for Hepatocellular Carcinoma: A Review of Recent Advances. Journal of Hepatocellular Carcinoma 2021; : 1035 doi: 10.2147/JHC.S291558
|
| 14 |
Leonard Christopher Schmeel, Frederic Carsten Schmeel, Christoph Coch, Ingo G. H. Schmidt-Wolf. Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC). Journal of Cancer Research and Clinical Oncology 2015; 141(5): 839 doi: 10.1007/s00432-014-1864-3
|
| 15 |
Bruno Sangro, Daniel Palmer, Ignacio Melero. Immunotherapy of Hepatocellular Carcinoma. Hepatic Oncology 2014; 1(4): 433 doi: 10.2217/hep.14.16
|
| 16 |
CONG CHEN, YIN-HUA MA, YA-TING ZHANG, FAN ZHANG, NING ZHOU, XIANG WANG, TAO LIU, YU-MIN LI. Effect of dendritic cell–based immunotherapy on hepatocellular carcinoma: A systematic review and meta-analysis. Cytotherapy 2018; 20(8): 975 doi: 10.1016/j.jcyt.2018.06.002
|
| 17 |
Behnoud Baradaran Noveiry, Armin Hirbod‐Mobarakeh, Nastaran Khalili, Niloufar Hourshad, Tim F Greten, Ghassan K Abou‐Alfa, Nima Rezaei. Specific immunotherapy in hepatocellular cancer: A systematic review. Journal of Gastroenterology and Hepatology 2017; 32(2): 339 doi: 10.1111/jgh.13449
|
| 18 |
Clara E. Jäkel, Annabelle Vogt, Maria A. Gonzalez-Carmona, Ingo G. H. Schmidt-Wolf. Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors. Journal of Immunology Research 2014; 2014: 1 doi: 10.1155/2014/897214
|
| 19 |
Uri Galili. The Natural Anti-Gal Antibody As Foe Turned Friend In Medicine. 2018; : 171 doi: 10.1016/B978-0-12-813362-0.00010-5
|
| 20 |
Uri Galili. Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes. Vaccine 2020; 38(42): 6487 doi: 10.1016/j.vaccine.2020.08.032
|
| 21 |
Meng-Yu Wu, Giuo-Teng Yiang, Pei-Wen Cheng, Pei-Yi Chu, Chia-Jung Li. Molecular Targets in Hepatocarcinogenesis and Implications for Therapy. Journal of Clinical Medicine 2018; 7(8): 213 doi: 10.3390/jcm7080213
|
| 22 |
Jing Cao, Fan-Hua Kong, Xi Liu, Xiao-Bo Wang. Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis. World Journal of Gastroenterology 2019; 25(27): 3649-3663 doi: 10.3748/wjg.v25.i27.3649
|
| 23 |
Uri Galili. Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.746883
|
| 24 |
Mark R. Albertini, Erik A. Ranheim, Cindy L. Zuleger, Paul M. Sondel, Jacquelyn A. Hank, Alan Bridges, Michael A. Newton, Thomas McFarland, Jennifer Collins, Erin Clements, Mary Beth Henry, Heather B. Neuman, Sharon Weber, Giles Whalen, Uri Galili. Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma. Cancer Immunology, Immunotherapy 2016; 65(8): 897 doi: 10.1007/s00262-016-1846-1
|
| 25 |
Yingying Huang, Yong Huang, Jian He, Huiling Wang, Yiqun Luo, Yanmei Li, Junjie Liu, Liping Zhong, Yongxiang Zhao. PEGylated immunoliposome-loaded endoglin single-chain antibody enhances anti-tumor capacity of porcine α1,3GT gene. Biomaterials 2019; 217: 119231 doi: 10.1016/j.biomaterials.2019.119231
|
| 26 |
Ender Gunes Yegin, Erkan Oymaci, Emrah Karatay, Ahmet Coker. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment. Hepatobiliary & Pancreatic Diseases International 2016; 15(3): 234 doi: 10.1016/S1499-3872(16)60097-8
|
| 27 |
Jeong-Hoon Lee, Joon Hyeok Lee, Young-Suk Lim, Jong Eun Yeon, Tae-Jin Song, Su Jong Yu, Geum-Youn Gwak, Kang Mo Kim, Yoon Jun Kim, Jae Won Lee, Jung-Hwan Yoon. Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up. Cancer Immunology, Immunotherapy 2019; 68(1): 23 doi: 10.1007/s00262-018-2247-4
|
| 28 |
Uri Galili. Natural anti-carbohydrate antibodies contributing to evolutionary survival of primates in viral epidemics?. Glycobiology 2016; doi: 10.1093/glycob/cww088
|
| 29 |
Shasha Song, Pingfan Yuan, Huaxun Wu, Jingyu Chen, Jingjing Fu, Peipei Li, Jingtao Lu, Wei Wei. Dendritic cells with an increased PD-L1 by TGF-β induce T cell anergy for the cytotoxicity of hepatocellular carcinoma cells. International Immunopharmacology 2014; 20(1): 117 doi: 10.1016/j.intimp.2014.02.027
|
| 30 |
Yasunari Nakamoto. Promising new strategies for hepatocellular carcinoma. Hepatology Research 2017; 47(4): 251 doi: 10.1111/hepr.12795
|
| 31 |
Xiu-Rong Cai, Xing Li, Jin-Xiang Lin, Tian-Tian Wang, Min Dong, Zhan-Hong Chen, Chang-Chang Jia, Ying-Fen Hong, Qu Lin, Xiang-Yuan Wu. Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review. Oncotarget 2017; 8(19): 31318 doi: 10.18632/oncotarget.15454
|
| 32 |
Shiroh Tanoue, Li-Yuan Chang, Yonghai Li, David E. Kaplan. Monocyte-derived dendritic cells from cirrhotic patients retain similar capacity for maturation/activation and antigen presentation as those from healthy subjects. Cellular Immunology 2015; 295(1): 36 doi: 10.1016/j.cellimm.2015.02.008
|
| 33 |
Thomas C Wirth. Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies. Expert Review of Gastroenterology & Hepatology 2014; 8(1): 101 doi: 10.1586/17474124.2014.862497
|
| 34 |
Current World Literature. Current Opinion in Allergy & Clinical Immunology 2012; 12(4): 440 doi: 10.1097/ACI.0b013e328356708d
|